Anika Therapeutics, Inc.
ANIK- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0000898437
In the last 90 days, Anika Therapeutics, Inc. insiders filed 1 open-market purchase and 0 sales; 133 institutions reported holding it in 13F filings for Q2 2026, worth $179.0M in total; no superinvestor holds it.
13F holders, Q1 2024
Institutional positions in Anika Therapeutics, Inc. as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 120
- +3 vs. Q4 2023
- Shares held
- 13.4M
- +151.7K (+1.1%) vs. Q4 2023
- Total value
- $340.4M
- +$40.2M (+13.4%) vs. Q4 2023
- New holders
- 14
- 43 more added
- Sold out
- 11
- 41 more reduced
Compare with Q4 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ANIK on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 133 | $179.0M |
| Q1 2026 | 130 | $179.1M |
| Q4 2025 | 126 | $117.5M |
| Q3 2025 | 117 | $115.0M |
| Q2 2025 | 104 | $134.2M |
| Q1 2025 | 108 | $190.7M |
| Q4 2024 | 109 | $206.2M |
| Q3 2024 | 122 | $323.5M |
| Q2 2024 | 114 | $335.3M |
| Q1 2024 | 120 | $340.4M |
| Q4 2023 | 117 | $300.2M |
| Q3 2023 | 117 | $242.3M |
| Q2 2023 | 117 | $340.4M |
| Q1 2023 | 121 | $375.6M |
| Q4 2022 | 125 | $388.0M |
| Q3 2022 | 123 | $320.5M |
| Q2 2022 | 126 | $302.2M |
| Q1 2022 | 119 | $341.4M |
| Q4 2021 | 127 | $483.3M |
| Q3 2021 | 131 | $559.5M |
| Q2 2021 | 139 | $568.9M |
| Q1 2021 | 146 | $543.0M |
Institutions, Q1 2024
Shares, value and share of portfolio for each institution holding Anika Therapeutics, Inc.; share changes are against Q4 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Nisa Investment Advisors, LLC | 374 | $9.50K | 0.00% | +10+2.7% | Added |
| Point72 (DIFC) Ltd | 370 | $9.40K | 0.00% | +370 | New |
| CWM, LLC | 280 | $7.00K | 0.00% | 00.0% | Unchanged |
| Rothschild Investment LLC | 275 | $6.99K | 0.00% | 00.0% | Unchanged |
| The PNC Financial Services Group, Inc. | 266 | $6.76K | 0.00% | +4+1.5% | Added |
| Barrett & Company, Inc. | 260 | $6.60K | 0.00% | 00.0% | Unchanged |
| Huntington National Bank | 201 | $5.11K | 0.00% | 00.0% | Unchanged |
| GAMMA Investing LLC | 178 | $4.52K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 144 | $3.66K | 0.00% | −2,960−95.4% | Reduced |
| Signaturefd, LLC | 103 | $2.62K | 0.00% | +18+21.2% | Added |
| Comerica Bank | 90 | $2.29K | 0.00% | 00.0% | Unchanged |
| Simplex Trading, LLC | 104 | $2.00K | 0.00% | −1,266−92.4% | Reduced |
| Russell Investments Group, Ltd. | 46 | $1.17K | 0.00% | +12+35.3% | Added |
| Covestor Ltd | 24 | $1.00K | 0.00% | +13+118.2% | Added |
| Parallel Advisors, LLC | 39 | $991 | 0.00% | +39 | New |
| Farther Finance Advisors, LLC | 37 | $951 | 0.00% | 00.0% | Unchanged |
| Quarry LP | 29 | $737 | 0.00% | +29 | New |
| Advisor Group Holdings, Inc. | 10 | $254 | 0.00% | −56,853−100.0% | Reduced |
| Versant Capital Management, Inc | 10 | $254 | 0.00% | 00.0% | Unchanged |
| Nelson, Van Denburg & Campbell Wealth Management Group, LLC | 3 | $76 | 0.00% | +3 | New |
| Invenomic Capital Management LP | 0 | $0 | 0.00% | −210,332−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −40,916−100.0% | Sold out |
| Man Group plc | 0 | $0 | 0.00% | −29,700−100.0% | Sold out |
| Balyasny Asset Management LLC | 0 | $0 | 0.00% | −14,605−100.0% | Sold out |
| Occudo Quantitative Strategies LP | 0 | $0 | 0.00% | −10,924−100.0% | Sold out |
| Aquatic Capital Management LLC | 0 | $0 | 0.00% | −3,700−100.0% | Sold out |
| Point72 Middle East FZE | 0 | $0 | 0.00% | −3,260−100.0% | Sold out |
| EntryPoint Capital, LLC | 0 | $0 | 0.00% | −1,937−100.0% | Sold out |
| Glassman Wealth Services | 0 | $0 | 0.00% | −10−100.0% | Sold out |
| Sofos Investments, Inc. | 0 | $0 | 0.00% | −4−100.0% | Sold out |
| Rosenberg Matthew Hamilton | 0 | $0 | 0.00% | −2−100.0% | Sold out |